Large Scale AAV For Preclinical Gene Therapy Studies

Source: Cytiva
iStock-1209892070-lab-cell-gene-microscope

UMMS and Cytiva collaboration to manufacture GLP grade viral vector suitable for primate studies

Your gene therapy candidate deserves to be a success. To fuel preclinical studies that use adeno-associated virus (AAV) for gene delivery, you need a ready supply of high-quality vector. Good laboratory practices (GLP) grade vector has the quality required for nonhuman primate studies and is a cost-effective option, because it avoids the infrastructure costs of good manufacturing practices (GMP) facilities. And the lead time to get GLP-grade vector could be much shorter.

You can get good laboratory practice (GLP)-grade vector from a new facility brought to you by Cytiva and the University of Massachusetts Medical School (UMMS). Here, you can access the combined benefits of Cytiva’s industry-leading development platforms and processing equipment plus UMMS’ professional and scientifically knowledgeable staff to help you get your research to the clinic faster.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: